BackUSFDA inspects Sharon Bio-Medicine’s Taloja unit
Sharon Bio-Medicine's Taloja unit was inspected and audited by USFDA for 7 days
Premium
New Delhi: Drug firm Sharon Bio-Medicine’s Taloja facility in Maharashtra that manufactures active pharmaceutical ingredients (API) has been inspected by the US health regulator.
One of the company’s unit located at Taloja in Raigad district in Maharashtra has been inspected and audited by United States Food and Drug Administration (USFDA) inspectors for 7 days starting from 29 June 2015, Sharon Bio-Medicine said in a filing to BSE. The audit was completed on 7July 2015, it added.
The company, however, did not provide any details about the findings of the inspection. Earlier the USFDA had issued a warning letter to the owner of the firm for failing to pay the appropriate facility fee for its Dehradun based facility as required by the Generic Drug User Fee Amendments of 2012 (GDUFA).
Shares of Sharon Bio-Medicine on Thursday closed at ₹ 20.38 per scrip on BSE, up 3.56% from its previous close.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!
